1 / 1

Supplementary Figure 1.

Supplementary Figure 1. In-stent LL, mean (SD), mm. Baseline characteristics. No. of patients. Difference (95% CI). Control. Celecoxib. P int. Sex Male Female Age ≥65 years <65 years Diabetes Yes No LAD Yes No Type C lesion Yes No DES

zaza
Télécharger la présentation

Supplementary Figure 1.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1. In-stent LL, mean (SD), mm Baseline characteristics No. of patients Difference (95% CI) Control Celecoxib P int Sex Male Female Age ≥65 years <65 years Diabetes Yes No LAD Yes No Type C lesion Yes No DES Paclitaxel Zotarolimus Cilostazol Yes No All 531 259 426 364 223 567 417 373 377 413 468 322 315 475 790 0.66 (0.56) 0.57 (0.51) 0.60 (0.50) 0.52 (0.40) 0.64 (0.55) 0.52 (0.45) 0.64 (0.54) 0.59 (0.50) 0.64 (0.57) 0.61 (0.50) 0.64 (0.53) 0.53 (0.46) 0.64 (0.52) 0.57 (0.48) 0.64 (0.57) 0.54 (0.46) 0.66 (0.56) 0.60 (0.49) 0.62 (0.53) 0.51 (0.46) 0.56 (0.50) 0.49 (0.45) 0.76 (0.58) 0.65 (0.50) 0.58 (0.53) 0.50 (0.41) 0.68 (0.55) 0.59 (0.50) 0.64 (0.54) 0.55 (0.47) -0.09 (-0.18 to 0.00) -0.07 (-0.19 to 0.04) -0.12 (-0.21 to -0.02) -0.02 (-0.15 to 0.06) -0.02 (-0.17 to 0.12) -0.11 (-0.19 to -0.03) -0.07 (-0.17 to 0.03) -0.10 (-0.20 to 0.01) -0.06 (-0.16 to -0.05) -0.11 (-0.21 to -0.02) -0.07 (-0.15 to 0.02) -0.11 (-0.23 to 0.01) -0.09 (-0.19 to 0.02) -0.09 (-0.18 to 0.01) -0.08 (-0.16 to -0.01) 0.83 0.35 0.28 0.70 0.46 0.58 1.00 -0.24 -0.12 0 0.12 Celecoxib better Control better

More Related